SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "LAR1:hb "

Sökning: LAR1:hb

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • 23rd Nordic Workshop on Bibliometrics and Research Policy 2018 Book of abstracts
  • 2018
  • Proceedings (redaktörskap) (övrigt vetenskapligt)abstract
    • Initiated by Professors Olle Persson and Peter Ingwersen, bibliometric researchers in the Nordic countries have arranged annual Nordic workshops on bibliometrics since 1996. The general scope of the Nordic Workshop on Bibliometrics and Research Policy is to present recent bibliometric research in the Nordic countries, to create better linkages between the bibliometric research groups and their PhD students, and to link bibliometric research with research policy.The workshop language is English and the workshop is open to participants from any nation. The 23rd Nordic Workshop on Bibliometrics and Research Policy (NWB’2018) was organized by the Swedish School of Library and Information Science (SSLIS) at University of Borås, Sweden. It was held at University of Borås, on November 7-9th, 2018 with 100 participants.In total, we received 35 submissions. After reviewing the submissions, the program committee decided which papers were to be presented orally and which as poster presentations. 21 papers were accepted as oral presentations. These, as well as the titles of the two invited keynote talks and the abstracts of 9 posters, are presented as abstracts in these proceedings. The posters and oral presentation slides are also available for viewing and peer-feedback at figshare (with citable DOIs):https://doi.orgWe would like to thank all authors for their submissions, the session chairs and the keynote speakers, Fredrik Åström and Merle Jacob, for their contributions to the workshop and the student volunteers, for their diligent efforts during the workshop. Further, we would like to thank the sponsors for their generous financial support, without which the Nordic workshops could not be organised in their current form.The NWB’2017 website is at https://hb.se/nwb2018Follow on twitter as @nwb_2018 and #nwb2018
  •  
2.
  •  
3.
  •  
4.
  • Aarnikoivu, Melina, et al. (författare)
  • Another higher education journal - Really?
  • 2019
  • Ingår i: Journal of Praxis in Higher Education. - Boras. - 2003-3605. ; 1:1, s. 1-9
  • Tidskriftsartikel (övrigt vetenskapligt)
  •  
5.
  • Aasa, Mikael, et al. (författare)
  • Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial.
  • 2010
  • Ingår i: American heart journal. - : Mosby, Inc.. - 1097-6744 .- 0002-8703. ; 160:2, s. 322-8
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: In ST-elevation myocardial infarction, primary percutaneous coronary intervention (PCI) has a superior clinical outcome, but it may increase costs in comparison to thrombolysis. The aim of the study was to compare costs, clinical outcome, and quality-adjusted survival between primary PCI and thrombolysis. METHODS: Patients with ST-elevation myocardial infarction were randomized to primary PCI with adjunctive enoxaparin and abciximab (n = 101), or to enoxaparin followed by reteplase (n = 104). Data on the use of health care resources, work loss, and health-related quality of life were collected during a 1-year period. Cost-effectiveness was determined by comparing costs and quality-adjusted survival. The joint distribution of incremental costs and quality-adjusted survival was analyzed using a nonparametric bootstrap approach. RESULTS: Clinical outcome did not differ significantly between the groups. Compared with the group treated with thrombolysis, the cost of interventions was higher in the PCI-treated group ($4,602 vs $3,807; P = .047), as well as the cost of drugs ($1,309 vs $1,202; P = .001), whereas the cost of hospitalization was lower ($7,344 vs $9,278; P = .025). The cost of investigations, outpatient care, and loss of production did not differ significantly between the 2 treatment arms. Total cost and quality-adjusted survival were $25,315 and 0.759 vs $27,819 and 0.728 (both not significant) for the primary PCI and thrombolysis groups, respectively. Based on the 1-year follow-up, bootstrap analysis revealed that in 80%, 88%, and 89% of the replications, the cost per health outcome gained for PCI will be <$0, $50,000, and $100,000 respectively. CONCLUSION: In a 1-year perspective, there was a tendency toward lower costs and better health outcome after primary PCI, resulting in costs for PCI in comparison to thrombolysis that will be below the conventional threshold for cost-effectiveness in 88% of bootstrap replications.
  •  
6.
  • Aasa, Mikael, et al. (författare)
  • Risk Reduction for Cardiac Events After Primary Coronary Intervention Compared With Thrombolysis for Acute ST-Elevation Myocardial Infarction (Five-Year Results of the Swedish Early Decision Reperfusion Strategy [SWEDES] Trial).
  • 2010
  • Ingår i: The American journal of cardiology. - : Excerpta Medica, Inc. - 1879-1913 .- 0002-9149. ; 106:12, s. 1685-91
  • Tidskriftsartikel (refereegranskat)abstract
    • Primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction compares favorably to thrombolysis. In previous studies the benefit has been restricted to the early postinfarction period with no additional risk decrease beyond this period. Long-term outcome after use of third-generation thrombolytics and modern adjunctive pharmaceutics in the 2 treatment arms has not been investigated. This study was conducted to compare 5-year outcome after updated regimens of PPCI or thrombolysis. Patients with ST-elevation myocardial infarction were randomized to enoxaparin and abciximab followed by PPCI (n = 101) or enoxaparin followed by reteplase (n = 104), with prehospital initiation of therapy in 42% of patients. Data on survival and major cardiac events were obtained from Swedish national registries after 5.3 years. PPCI resulted in a better outcome with respect to the composite of death or recurrent myocardial infarction (hazard ratio 0.54, confidence interval 0.31 to 0.95) compared to thrombolysis. This was attributed to a significant decrease in cardiac deaths (hazard ratio 0.16, confidence interval 0.04 to 0.74). The difference evolved continuously over the 5-year follow-up. After adjustment for covariates, a significant benefit remained with respect to cardiac death or recurrent infarction but not for the composite of total survival or recurrent myocardial infarction (p = 0.07). The observed differences were not seen in patients in whom therapy was initiated in the prehospital phase. In conclusion, PPCI in combination with enoxaparin and abciximab compares favorably to thrombolysis in combination with enoxaparin with a risk decrease that stretches beyond the early postinfarction period. Prehospital thrombolysis may, however, match PPCI in long-term outcome.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (4135)
konferensbidrag (3067)
bokkapitel (998)
rapport (711)
annan publikation (579)
recension (338)
visa fler...
doktorsavhandling (302)
bok (163)
konstnärligt arbete (154)
samlingsverk (redaktörskap) (97)
licentiatavhandling (68)
forskningsöversikt (62)
proceedings (redaktörskap) (19)
patent (9)
visa färre...
Typ av innehåll
refereegranskat (5862)
övrigt vetenskapligt (3900)
populärvet., debatt m.m. (788)
Författare/redaktör
Herlitz, Johan (596)
Taherzadeh, Mohammad ... (242)
Herlitz, Johan, 1949 (227)
Maceviciute, Elena (202)
Herlitz, J (200)
Skrifvars, Mikael (190)
visa fler...
Sundström, Malin, 19 ... (184)
Karlson, BW (169)
Karlsson, T (159)
Wolmesjö, Maria, 196 ... (158)
Hjalmarson, Å (147)
Taherzadeh, Mohammad ... (143)
Maceviciute, Elena, ... (122)
Beach, Dennis (113)
Nyström, Maria (110)
Svensson, L (106)
Ekström, Karin M. (101)
Holmberg, S (99)
Hartford, M (98)
Sundström, Malin (93)
Ekebergh, Margaretha (92)
Bolton, Kim (91)
Cronholm, Stefan (91)
Haider, Jutta (89)
Nierstrasz, Vincent, ... (85)
Sandman, Lars (85)
Suserud, Björn-Ove (84)
Limberg, Louise (79)
Lindqvist, J (78)
Lundberg, Lars (74)
Lind, Mikael (74)
Caidahl, K (72)
Sárvári Horváth, Ilo ... (72)
Beach, Dennis, 1956 (71)
Francke, Helena (71)
Johansson, Ulf (70)
Svensson, Leif (70)
Sundin, Olof (70)
Dellve, Lotta (69)
Salomonson, Nicklas (67)
Wittek, Peter (65)
Bång, A (64)
Aldrin, Viktor, 1980 ... (63)
Frenander, Anders (63)
Nolin, Jan (62)
Taherzadeh, Mohammad (60)
Brorström, Björn (59)
Lindecrantz, Kaj (59)
Ståhl, Fredrik (59)
Skrifvars, Mikael, 1 ... (59)
visa färre...
Lärosäte
Högskolan i Borås (10552)
Göteborgs universitet (479)
Jönköping University (200)
Linköpings universitet (172)
Chalmers tekniska högskola (170)
Linnéuniversitetet (117)
visa fler...
Kungliga Tekniska Högskolan (106)
Lunds universitet (73)
Högskolan i Skövde (65)
Uppsala universitet (56)
Karolinska Institutet (44)
RISE (41)
Högskolan i Halmstad (39)
Umeå universitet (37)
Karlstads universitet (33)
Stockholms universitet (28)
Örebro universitet (26)
Mälardalens högskola (23)
Luleå tekniska universitet (22)
Mittuniversitetet (19)
Malmö universitet (17)
Högskolan Väst (11)
Högskolan Dalarna (9)
Högskolan Kristianstad (5)
Södertörns högskola (4)
Högskolan i Gävle (4)
Ersta Sköndal Bräcke högskola (4)
Sveriges Lantbruksuniversitet (4)
Gymnastik- och idrottshögskolan (3)
Blekinge Tekniska Högskola (1)
visa färre...
Språk
Engelska (7281)
Svenska (3115)
Tyska (59)
Norska (27)
Danska (16)
Litauiska (15)
visa fler...
Portugisiska (7)
Spanska (6)
Finska (5)
Franska (4)
Polska (4)
Rumänska (3)
Italienska (2)
Ungerska (2)
Odefinierat språk (1)
Arabiska (1)
Tjeckiska (1)
Kroatiska (1)
Turkiska (1)
Katalanska (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Samhällsvetenskap (4680)
Medicin och hälsovetenskap (1503)
Teknik (1413)
Naturvetenskap (1030)
Humaniora (750)
Lantbruksvetenskap (29)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy